BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 15357661)

  • 1. Oxidation of melatonin and its catabolites, N1-acetyl-N2 -formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine, by activated leukocytes.
    Silva SO; Rodrigues MR; Carvalho SR; Catalani LH; Campa A; Ximenes VF
    J Pineal Res; 2004 Oct; 37(3):171-5. PubMed ID: 15357661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized synthesis of the melatonin metabolite N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK).
    Ximenes VF
    J Pineal Res; 2008 Oct; 45(3):297-301. PubMed ID: 18373552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages.
    Mayo JC; Sainz RM; Tan DX; Hardeland R; Leon J; Rodriguez C; Reiter RJ
    J Neuroimmunol; 2005 Aug; 165(1-2):139-49. PubMed ID: 15975667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel pathway for N1-acetyl-5-methoxykynuramine: UVB-induced liberation of carbon monoxide from precursor N1-acetyl-N2-formyl-5-methoxykynuramine.
    Seever K; Hardeland R
    J Pineal Res; 2008 May; 44(4):450-5. PubMed ID: 18194200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophils as a specific target for melatonin and kynuramines: effects on cytokine release.
    Silva SO; Rodrigues MR; Ximenes VF; Bueno-da-Silva AE; Amarante-Mendes GP; Campa A
    J Neuroimmunol; 2004 Nov; 156(1-2):146-52. PubMed ID: 15465605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase-catalyzed oxidation of melatonin by activated neutrophils.
    Silva SO; Ximenes VF; Catalani LH; Campa A
    Biochem Biophys Res Commun; 2000 Dec; 279(2):657-62. PubMed ID: 11118341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction.
    Ressmeyer AR; Mayo JC; Zelosko V; Sáinz RM; Tan DX; Poeggeler B; Antolín I; Zsizsik BK; Reiter RJ; Hardeland R
    Redox Rep; 2003; 8(4):205-13. PubMed ID: 14599344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Melatonin and its kynurenin-like oxidation products affect the microbicidal activity of neutrophils.
    Silva SO; Carvalho SR; Ximenes VF; Okada SS; Campa A
    Microbes Infect; 2006 Feb; 8(2):420-5. PubMed ID: 16242372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidation of melatonin and tryptophan by an HRP cycle involving compound III.
    Ximenes VF; Catalani LH; Campa A
    Biochem Biophys Res Commun; 2001 Sep; 287(1):130-4. PubMed ID: 11549265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactions of the NO redox forms NO+, *NO and HNO (protonated NO-) with the melatonin metabolite N1-acetyl-5-methoxykynuramine.
    Hardeland R; Backhaus C; Fadavi A
    J Pineal Res; 2007 Nov; 43(4):382-8. PubMed ID: 17910607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of N1-acetyl-N2-formyl-5-methoxykynuramine/N1-acetyl-5-methoxy-kynuramine formation from melatonin in mice.
    Niu S; Li F; Tan DX; Zhang L; Idle JR; Gonzalez FJ; Ma X
    J Pineal Res; 2010 Sep; 49(2):106-14. PubMed ID: 20545825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The co-catalytic effect of chlorpromazine on peroxidase-mediated oxidation of melatonin: enhanced production of N1-acetyl-N2-formyl-5-methoxykynuramine.
    Ximenes VF; Rodrigues AP; Cabello C; de Menezes ML; Fernandes JR
    J Pineal Res; 2008 Mar; 44(2):115-20. PubMed ID: 18289161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats.
    Rozov SV; Filatova EV; Orlov AA; Volkova AV; Zhloba AR; Blashko EL; Pozdeyev NV
    J Pineal Res; 2003 Nov; 35(4):245-50. PubMed ID: 14521629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concentrations of the melatonin metabolite, N1-acetyl-N2-formyl-5-methoxykynuramine, in cerebrospinal fluid of patients with meningitis: a possible immunomodulatory mechanism.
    Silva SO; Ximenes VF; Livramento JA; Catalani LH; Campa A
    J Pineal Res; 2005 Oct; 39(3):302-6. PubMed ID: 16150112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger.
    Schaefer M; Hardeland R
    J Pineal Res; 2009 Jan; 46(1):49-52. PubMed ID: 18643875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK.
    Guenther AL; Schmidt SI; Laatsch H; Fotso S; Ness H; Ressmeyer AR; Poeggeler B; Hardeland R
    J Pineal Res; 2005 Oct; 39(3):251-60. PubMed ID: 16150105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactions of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products.
    Than NN; Heer C; Laatsch H; Hardeland R
    Redox Rep; 2006; 11(1):15-24. PubMed ID: 16571272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of pH on horseradish peroxidase-catalyzed oxidation of melatonin: production of N1-acetyl-N2-5-methoxykynuramine versus radical-mediated degradation.
    Ximenes VF; Fernandes JR; Bueno VB; Catalani LH; de Oliveira GH; Machado RG
    J Pineal Res; 2007 Apr; 42(3):291-6. PubMed ID: 17349028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioimmunoassay of N-acetyl-N-formyl-5-methoxykynuramine (AFMK): a melatonin oxidative metabolite.
    Harthé C; Claudy D; Déchaud H; Vivien-Roels B; Pévet P; Claustrat B
    Life Sci; 2003 Aug; 73(12):1587-97. PubMed ID: 12865098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between melatonin and nicotinamide nucleotide: NADH preservation in cells and in cell-free systems by melatonin.
    Tan DX; Manchester LC; Sainz RM; Mayo JC; Leon J; Hardeland R; Poeggeler B; Reiter RJ
    J Pineal Res; 2005 Sep; 39(2):185-94. PubMed ID: 16098097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.